Covalon Technologies Ltd. (OTCMKTS:CVALF) Short Interest Update

Covalon Technologies Ltd. (OTCMKTS:CVALF) was the recipient of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 1,000 shares, a drop of 86.3% from the May 31st total of 7,300 shares. Based on an average daily trading volume, of 3,500 shares, the days-to-cover ratio is presently 0.3 days.

Covalon Technologies Stock Performance

Shares of OTCMKTS CVALF remained flat at $1.55 during trading on Friday. The business has a 50-day moving average of $1.13 and a 200 day moving average of $0.95. Covalon Technologies has a 1 year low of $0.73 and a 1 year high of $1.73.

Covalon Technologies (OTCMKTS:CVALF) last posted its quarterly earnings data on Wednesday, May 29th. The company reported $0.04 EPS for the quarter. Covalon Technologies had a negative return on equity of 14.53% and a negative net margin of 10.61%. The firm had revenue of $6.22 million for the quarter.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.